Baird Medical Sponsored and Showcased Microwave Ablation (MWA) Technology at the 7th Thyroid Disease Forum in China

BDMD 11.25.2024

Full Press ReleaseSEC FilingsOur BDMD Tweets

About Gravity Analytica

Recent News

  • 01.22.2025 - Baird Medical Expands into San Francisco, Advancing U.S. Market Growth
  • 01.21.2025 - Dr. Emad Kandil Achieves Milestone of 100 Microwave Ablation Cases in Thyroid Care
  • 01.17.2025 - Baird Medical Engages with Healthcare Leaders Amid 2025 J.P. Morgan Healthcare Conference

Recent Filings

  • 01.17.2025 - F-1/A Registration statement for certain foreign private issuers
  • 01.10.2025 - S-8 Securities to be offered to employees in employee benefit plans

NEW YORK,Nov. 25, 2024/PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a global leader in minimally invasive microwave ablation (MWA) technology, proudly sponsored and participated in the 2024 7thThyroid Disease Standardized Diagnosis and Treatment ForumandGuangdong Pharmaceutical Society Thyroid Specialist CommitteeAnnual Meeting, held inGuangzhou, China.

2024 7th Thyroid Disease Forum and Guangdong Thyroid Specialist Committee Annual Meeting

This prestigious forum, hosted by theGuangdong Provincial People's Hospitaland organized by leading medical and pharmaceutical associations inGuangdong, brought together top experts and healthcare professionals to advance standardized treatment protocols for thyroid diseases. Recognized as a premier platform for academic exchange and technological innovation, the event provided an invaluable opportunity to explore the latest advancements in thyroid care.

As a sponsor, Baird Medical presented its advanced microwave ablation technology, designed to provide precise, efficient, and minimally invasive options for thyroid treatments. Attendees had the opportunity to learn about Baird's innovations, which enable larger ablation zones and shorter treatment times, setting a new standard for minimally invasive procedures.

"Baird Medical is thrilled to sponsor and contribute to this highly respected forum, which underscores our dedication to advancing cutting-edge solutions for thyroid disease management," said Haimei Wu, Chairwoman of Baird Medical. "Through our participation, we aim to support medical professionals with the tools and expertise needed to improve patient outcomes globally."

The forum also enabled Baird Medical to engage in meaningful discussions with leading experts, enhance collaborations, and highlight its commitment to expanding the reach of innovative treatments both withinChinaand globally. Sponsoring this influential event further solidifies Baird Medical's position as a leader in the field of minimally invasive treatments for thyroid diseases.

About Baird MedicalBaird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visithttps://bairdmed.com/

Baird Medical (PRNewsfoto/Baird Medical LLC)

CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-sponsored-and-showcased-microwave-ablation-mwa-technology-at-the-7th-thyroid-disease-forum-in-china-302315066.html

SOURCE BDMD

Eric Huang, PR Liaison, Baird Medical LLC, Phone: +1 (888) 508-6228, Email: erichuang@bairdmed.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com